Patents
Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
10/2008
10/23/2008US20080262246 Novel chemical intermediates; reacting with organometallic compound
10/23/2008US20080262224 Method of Preparation of Benzofuran-2-Carboxylic Acid -Amide
10/23/2008US20080262139 A novolak structure modified by nitrogen-containing or silicon-containing compound may collocate with inorganic powder; high heat resistance and glass transition temperature, low expansion, hydrophobic; prepregs used in copper clad laminates or printed circuit plates
10/23/2008US20080262082 S-(-)-tulipalin B, acetylated-S-(-)-tulipalin B and an antibacterial composition comprising the same. The active compound tulipalin B and composition of the present invention exhibit superior and stable antibacterial activity over a broad range of temperature and pH
10/23/2008US20080262032 Isoxazoline Derivative and Novel Process for Its Preparation
10/23/2008US20080261994 4-[5-((1S,2R)-1-Carboxy-2-phenyl-cyclopropylsulfamoyl)-thiophen-2-yl]-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester; aggrecanase and matrix metalloproteinase (with zinc in the catalytic active center) inhibitor; antiarthritic agent: osteoarthritis, rheumatoid arthritis
10/23/2008US20080261993 surprisingly active in the control of insects and acarids; admixture with pesticides, plant growth regulators, fertilizers and soil conditioners
10/23/2008US20080261967 Modulators of Central Nervous System Neurotransmitters
10/23/2008DE102007018148A1 Preparation of alkene, which is a polymer compound, preferably homopolymer, copolymer or block-copolymer, comprises metathesis reaction of unsaturated compound containing an alkene or alkyne unit in the presence of an active catalyst
10/22/2008EP1982976A1 Process for the manufacture of non-steroidal anti-inflammatory agents and intermediates thereof
10/22/2008EP1981867A2 Method for preparing prostaglandin derivative
10/22/2008EP1981866A1 Fungicide n-cycloalkyl-benzyl-amide derivatives
10/22/2008EP1981865A1 4-phenyl-3-(2-propylsulfonylamino) tetrahydrofuran derivatives which potentiate glutamate receptors and are useful in the treatment of schizophrenia
10/22/2008EP1981864A1 Compounds which potentiate glutamate receptor and uses thereof in medicine
10/22/2008EP1981837A2 Methods and compositions for modulating sphingosine-1-phosphate (s1p) receptor activity
10/22/2008EP1706394A4 Preparation of escitalopram
10/22/2008CN101292039A Method for producing cercosporamide
10/22/2008CN101289438A 3-(3í»-hydroxyl)-butyl phthalide ester, and preparation thereof and uses
10/22/2008CN101289437A Process for separating gibberellin A4 from the mixture of gibberellin A4 and A7
10/22/2008CN101289436A Process for preparing furfural
10/22/2008CN101289435A Process for preparing 5-hydroxymethyl-furfural
10/22/2008CN101289434A 1,5-difuranyl pentadienones, preparation method and sterilization activity thereof
10/22/2008CN101289433A Method for preparing alpha, beta-2-dibrom furan chlcones and sterilization activity thereof
10/22/2008CN100427482C N,N-dimethylaminoacyl-2,3-difuryl-6-aminoquinoxaline, preparation method and application thereof
10/22/2008CN100427472C Aryl-heteroaromatic products, compositions containing same and use thereof
10/21/2008US7439373 X-ray powder diffraction; antitumor agents
10/21/2008US7439368 Process for producing 3-acylaminobenzofuran-2-carboxylic acid derivative
10/21/2008US7439266 Malononitrile compound and use thereof
10/21/2008CA2146707C Substituted n-heteroaroylguanidines as inhibitors of na+/h+ exchange
10/16/2008WO2008123469A1 Six-membered amide compound and use thereof
10/16/2008WO2008123349A1 Method for producing n-phenyl-n'-phenylsulfonylpiperazine derivative
10/16/2008WO2008123067A1 Method for asymmetric hydrogenation of allyl amine
10/16/2008WO2008083950A3 Spirocyclic tetronic acid derivatives
10/16/2008WO2008048668A3 Novel inhibitors of chymase
10/16/2008WO2008024302A3 Compounds for treating proliferative disorders
10/16/2008US20080255377 Processes for the Manufacture of Chiral and Racemic Forms of 3-Aminotetrahydrofurans, Their Salts and Derivatives
10/16/2008US20080255374 Process for charging a longitudinal section of a catalyst tube
10/16/2008US20080255230 Pain therapy; muscular disorders; diarrhea
10/16/2008US20080255221 Novel hydroxamates as therapeutic agents
10/16/2008US20080255214 Novel hydroxamates as therapeutic agents
10/16/2008US20080255198 Biaryloxymethylarenecarboxylic acids as glycogen synthase activator
10/16/2008US20080255152 Diaryl ethers as opioid receptor antagonists
10/16/2008US20080255144 (3'-Chloro-4-methanesulfonyl-biphenyl-2-yl)-[4-(3,4-dichloro-phenyl)-piperazin-1-yl]-methanone; neurological and neuropsychiatric disorders including schizophrenia
10/16/2008US20080255126 Inhibitors of post-proline cleaving proteases
10/16/2008US20080255042 CaSR Antagonist
10/16/2008US20080254520 By controlling level of carbohydrates (starch, molasses) during Penicillium biodegradation; crystalline E-8-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydro-isobenzofuran-5-yl)-2,6-dimethyl-oct-6-enoic acid
10/15/2008EP1979311A2 Phenoxy acetic acids as ppar delta activators
10/15/2008EP1763506B1 Method for producing nitriles by elimination of water from aldehyde oximes with alkylphosphonic anhydrides
10/15/2008EP1716108B1 Method for the separation of intermediates which may be used for the preparation of escitalopram
10/15/2008EP1692124B1 Biaryl sulfonamides as mmp inhibitors
10/15/2008EP1308436B1 Calcium receptor antagonists
10/15/2008EP1142872B1 Aromatic heterocycle compounds having hiv integrase inhibiting activities
10/15/2008EP0923544B1 Method for the synthesis of amines and amino acids with organoboron derivatives
10/15/2008CN101287719A Cholinergic enhancers with improved blood-brain barrier permeability for the treatment of diseases accompanied by cognitive impairment
10/15/2008CN101284825A Synthetic method of tetramethylene maleic anhydride
10/15/2008CN101284824A Preparation method of cenolate
10/15/2008CN101284823A Arctigenin pro-drug, preparation method and use thereof
10/15/2008CN101284808A Compounds and methods for the inhibition of the expression of VCAM-1
10/15/2008CN101284755A Chemical synthesis process for conjugated alkenes compounds
10/15/2008CN101284242A Catalyst for producing maleic anhydrid(e) by benzene gas-phase oxidation with high load and high yield
10/15/2008CN101283998A Application of bromine phenolic compound in preparing the medicine for curing the malignancy
10/15/2008CN101283997A Application of bromine phenolic compound in preparing the medicine for curing the ischemic cardio-vascular and cerebrovascular diseases
10/15/2008CN100425604C Process for supersonically extracting usnic acid
10/15/2008CN100425603C Compound with anti cerebralischemia, myo cardialischemia and memory-improving functions, and its preparing method and use
10/15/2008CN100425602C Diamine, acid dianhydride, polyimide composition having reactive group obtained therefrom, and processes for producing these
10/14/2008US7435843 Thiobenzoic acid, N-malonylhydrazide in which the free carboxy group is protected; enhances the desirable tumor attacking properties of anticancer agents without further increasing undesirable side-effects
10/14/2008US7435838 Mixture of both S- and R-enantiomers of 3-hydroxymethyl-4-[1-(p-fluorophenyl)-1-hydroxyl-4-(dimethylamino)]butylbenzonitrile; dissolving the intermediate free base oil in a single- or multi-component solvent, and crystallizing one or more times
10/14/2008US7435837 Serotonin receptors agonists; central nervous system disorders; schizophrenia, anxiety disorders, bipolar disorders, obesity; 1-[7-(2,3-dimethylphenyl)-2,3-dihydro-1-benzofuran-2-yl]methanamine; side effect reduction; antipsychotic
10/14/2008US7435756 Preparation and diabetic use of gibberellins
10/14/2008US7435318 Adding entrainers such as 1-ethyl-3-methylimidazolium tetrafluoroborate to liquid mixtures, then distilling the mixtures; efficiency
10/14/2008CA2309328C Cyclic amine derivatives and their use as drugs
10/09/2008WO2008120093A1 Sulfonamides and pharmaceutical compositions thereof
10/09/2008WO2008024304A3 Compounds for treatment of proliferative disorders
10/09/2008US20080249319 Process for the preparation of 5-Carboxyphthalide
10/09/2008US20080249252 New permanent surface modifiers
10/09/2008US20080249119 Nucleosiding a protected cytosine with a protected hexose, deprotecting to obtain gemcitabine; administering as produgs; cancers of the lungs, ovaries, pancreas and bladder; cost efficiency; simplification
10/09/2008US20080249107 Comprising trihydroxy phenyl subunits; selectin inhibitors; side effect reduction; 3-{3-[3-(3,4,5-Trihydroxy-phenyl)-propionylamino]-phenylamino}-benzoic acid
10/08/2008EP1978012A1 Alternative synthesis of renin inhibitors and intermediates thereof
10/08/2008EP1977646A1 Insecticidal hydroxyethyl thlourea derivatives
10/08/2008EP1976839A2 Compounds and methods for modulating protein trafficking
10/08/2008EP1976827A2 Method for producing methionine from homoserine
10/08/2008EP1976382A2 Process for preparing a synthetic intermediate for preparation of branched nucleosides
10/08/2008EP1539693B9 Cannabinoid receptor agonists
10/08/2008EP1352904B1 (meth)acrylate esters, starting alcohols for the preparation thereof, processes for preparing both, polymers of the esters, chemically amplifiable resist compositions, and method for forming patterns
10/08/2008CN101282957A 新的药物化合物 New pharmaceutical compounds
10/08/2008CN101282956A Anti-malarial compound isolated from gomphostema niveum
10/08/2008CN101282933A Novel NK1 and NK2 antagonists
10/08/2008CN101279964A Guaiane type sesquiterpenes, preparation and medical use thereof
10/08/2008CN101279963A Preparation of darifenacin intermediate 5-(halogenated ethyl)-2,3-dihydrobenzofuran
10/08/2008CN101279962A Method for preparing L-ascorbyl palmitate from biodiesel by-product
10/08/2008CN100424062C Process for preparing hydroaromatic polybasic carboxylic acid and process for preparing hydroaromatic polybasic carboxylic anhydride
10/07/2008US7432389 Inhibiting beta-secretase enzyme activity and A beta peptide production, to reduce amyloid beta deposits or plaques
10/07/2008US7432382 Conversion of 2,5-(hydroxymethyl)furaldehyde to industrial derivatives, purification of the derivatives, and industrial uses therefor
10/07/2008US7432303 Chalcone and its analogs as agents for the inhibition of angiogenesis and related disease states
10/07/2008US7432302 Treating proliferative cutaneous disease using a polyamine acylated with a hydrophobic acyl group, where acylation is by formation of either an amide or a sulfonamide linkage; e.g. lupus; use with other biosynthesis enzyme inhibitors
10/07/2008US7432290 Claimed is 1-Cyanobutan-2-yl-1-[3-[3-[3-methoxy-4-(oxazol-5-yl)phenyl]ureido]phenyl] ethylcarbamate, AVN 944, VX-944
10/07/2008US7432289 5-Acylamino-1,1′-biphenyl-4-carboxamide derivatives and their use as P38 kinase inhibitors
10/07/2008US7432281 4-(2,2-dichloro)-N-(quinolin-3-yl)benzamide; (1R,2R)2-methyl-N-(quinolin-3-yl)-4-(2-(trifluoromethyl)cyclopropyl)benzamide; inflammation-related conditions in mammals, arthritis, Parkinson's/Alzheimer's diseases, stroke, asthma; acute/chronic or neuropathic pain; VR1 agonist/antagonist
10/07/2008US7432264 Antibacterial compounds such as (S)-2-cyano-1-(trans-4-(5-nitro-2-pyridylamino)cyclohexylamino )acetylpyrrolidine; activity against Gram-negative and Gram-positive pathogens, including a methicillin-resistant S. aureus strain
10/07/2008US7432263 Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them